Free Trial
OTCMKTS:MSLP

MusclePharm (MSLP) Stock Price, News & Analysis

MusclePharm logo

About MusclePharm Stock (OTCMKTS:MSLP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
26,442 shs
Market Capitalization
$7,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.

Receive MSLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter.

MSLP Stock News Headlines

Only a handful of people know the setup that's defied these chaotic markets.
Since February, we've hit 28 out of 29 trades – that's a 96% win rate taking simple options setups on one single ticker every day. That's why Jack Carter and I teamed up to reveal The 4PM Payout Plan. Our goal here was to show you how to take these daily setups every morning to collect a 4PM payout. Naturally, no one can guarantee what the market does in the future… But these simple daily options setups have paid out with the market rallying, dropping, or staying flat. And if you want to be one of the few to not just know the ropes behind these daily setups but also deploy them for yourself…
The 5 best muscle rubs of 2024
See More Headlines

MSLP Stock Analysis - Frequently Asked Questions

MusclePharm Co. (OTCMKTS:MSLP) announced its quarterly earnings results on Monday, August, 10th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by $0.32. The firm earned $50.48 million during the quarter, compared to analyst estimates of $55 million.

Shares of MSLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MusclePharm investors own include Altimmune (ALT), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), BellRing Brands (BRBR), Dalradian Resources (DALR), EVRAZ (EVRZF) and Humacyte (HUMA).

Company Calendar

Last Earnings
8/10/2015
Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:MSLP
Fax
N/A
Employees
20
Year Founded
2008

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.87 million
Pretax Margin
-38.52%

Debt

Sales & Book Value

Annual Sales
$50.04 million
Price / Cash Flow
N/A
Book Value
($0.94) per share
Price / Book
N/A

Miscellaneous

Free Float
13,121,000
Market Cap
$7,000.00
Optionable
Not Optionable
Beta
-0.07

Social Links

Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (OTCMKTS:MSLP) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners